GENOCEA BIOSCIENCES, INC. — Form D

GENOCEA BIOSCIENCES, INC. of CAMBRIDGE, MA, a company, filed a Form D exempt-offering notice with the SEC on 2012-10-11. The offering totals $30.5M, of which $15.3M was reported sold. Industry: Biotechnology.

Offering

Issuer

Officers, directors & promoters (35)

Showing 25 of 35 people.

NameRoleLocation
Leon ChenDirectorAustin, TX
Thomas DavisExecutive OfficerHAMILTON, D0
George SiberDirectorIrvine, CA
Simeon GeorgeDirectorRedwood City, CA
William ClarkExecutive OfficerAUSTIN, TX
Ali BehbahaniDirectorLittleton, CO
Kevin BittermanDirectorCambridge, MA
Stephen HoffmanDirectorVancouver, A1
Asish XavierDirectorSouth San Francisco, CA
MICHAEL HIGGINSDirectorFRAMINGHAM, MA
Howard MayerDirectorWaltham, MA
Steve HoffmanDirectorReston, VA
JESSICA FLECHTNERExecutive OfficerCAMBRIDGE, MA
KATRINE BOSLEYDirectorCAMBRIDGE, MA
GIRISH AAKALUExecutive OfficerCAMBRIDGE, MA
DIANTHA DUVALLExecutive OfficerCAMBRIDGE, MA
GISELA SCHWABDirectorCAMBRIDGE, MA
KENNETH BATEDirectorCAMBRIDGE, MA
RONALD COOPERDirectorCAMBRIDGE, MA
Robert PaullDirectorBoston, MA
Narinder SinghExecutive OfficerOakland, CA
Derek MeisnerExecutive OfficerCambridge, MA
Michael AlfieriExecutive OfficerCambridge, MA
Pamela CarrollExecutive OfficerCambridge, MA
RAVI BAKER VENKATARAMANIExecutive OfficerCAMBRIDGE, MA

Other filings by this issuer (5)

FiledFormOfferingSold
2020-08-03D$79.9M$75.5M
2019-02-27D$15.0M$12.1M
2013-10-10D$400K$400K
2013-07-02D/A$30.5M$30.5M
2011-01-03D$35.1M$35.1M

More